Capital Resource Partners Purchases Gamma Medica Pre-Clinical Business to Form New Entity,Trifoil

NORTHRIDGE, Calif. - May 8, 2013 - PRLog -- Trifoil Imaging , formerly the Pre-Clinical division of Gamma Medica – Ideas (GMI), today formally announced its launch as a separate entity after being purchased by Capital Resource Partners (http://www.crp.com/index.htm).  With the same proven senior management team at the helm, Trifoil will focus on driving product innovation in the in-vivo molecular imaging market with its one-of-a-kind TriumphTM tri-modality and eXplore CT-120 products.

“Capital Resource Partners invests in companies that have established themselves as groundbreakers in their market. Trifoil’s already robust in-vivo molecular imaging business represents exactly this type of opportunity,” said Robert C. Ammerman, Managing Partner, Capital Resource Partners. “We are delighted that the talented management team from GMI’s Pre-Clinical division has agreed to remain with Trifoil, and we are proud of what they have accomplished while managing through GMI’s Chapter 11 process. Our investment represents our commitment to continuing to develop a business we believe has great potential for further growth.”

With an installed base of 300 imaging systems worldwide, Trifoil Imaging will continue to serve the world’s leading research laboratories with the company’s flagship TriumphTM system. TriumphTM, the world’s first tri-modality system, offers researchers the highest quality and best value by combining three modalities (PET, SPECT, and CT) all in one reliable and easy-to-use system.  eXplore CT 120 is a dedicated pre-clinical in-vivo MicroCT scanner designed for high-quality, high-throughput scanning in a wide variety of applications. It is the only CT system able to provide a true cardiac-gated pre-clinical imaging capability.

“For years, our team has worked with the world’s foremost universities, pharmaceutical companies and contract research organizations to provide their researchers with the highest quality imaging technologies and we look forward to continuing our work with global customers and prospects,” said Kevin Parnham, President and CEO, Trifoil Imaging . “Separating from Gamma Medica Inc. will empower our team to focus on in-vivo molecular imaging solutions without the distractions of technology aimed at other markets, increasing Trifoil’s chances of future successes.”

About Trifoil Imaging Inc.

Leading research laboratories around the world depend on Trifoil Imaging (formerly Gamma Medica – Ideas Pre-Clinical) technology to meet all their advanced in-vivo molecular imaging needs.  TriumphTM is the world’s first tri-modality system (including PET, SPECT, and CT) to offer the highest quality and the best value by combining three modalities all in one reliable and easy-to-use system. Founded in 2001 and now owned by Capital Resource Partners, Trifoil is headquartered in Northridge, California. Please visit www.trifoilimaging.com to learn more.

About Capital Resource Partners

Founded in 1987, Capital Resource Partners specializes in combined debt and equity structures that provide creative financing alternatives for middle-market firms. CRP invests in companies with proven business models that possess strong positions in attractive, and often times, niche markets.  Offering a flexible and long term solution to business owners, CRP considers a variety of transactions including:  growth, recapitalization and change of control. Based in Boston, CRP has invested in excess of $1.0 billion in middle market firms. For more information, visit www.crp.com.

Media Inquiries

Carole Hutchinson

BluePoint Venture Marketing for Trifoil Imaging Inc.

carole@bluepointmktg.com

617.372.3929